semaglutide interaction Understanding How Works: A Comprehensive Review Is there a clinically significant

Description

GLP-1 receptor agonists like Ozempic may pose risks for patients with ulcerative colitis

2023 Feb 17;15(4):1013

Resistant fiber and starches pass through the small intestine and reach the large intestine where they are fermented by gut bacteria nourishing beneficial bacteria and promoting microbial diversity while insoluble fibers add bulk to stool

Migliaccio & Rathod LLP is investigating the Veracity Metabolism Ignite GLP-1 Supplement

Indications: Type 2 Diabetes Mellitus (monotherapy or add-on therapy) Especially useful in patients who cannot tolerate metformin or sulfonylureas Can be used in elderly and patients with mild renal impairment Approved Agents in India: Sitagliptin (Januvia) Vildagliptin (Galvus) Saxagliptin (Onglyza) Linagliptin (Trajenta) No renal dose adjustment needed Alogliptin (Nesina) Dosing: Once daily oral dosing Some agents require renal dose adjustment (except Linagliptin) Often combined with metformin or SGLT2 inhibitors Side Effects: Nasopharyngitis, headache GI upset (mild) Rare: Acute pancreatitis, severe joint pain, skin reactions Saxagliptin may slightly increase risk of heart failure in some patients Advantages Over Other Classes: Weight neutral Low risk of hypoglycemia Well tolerated in the elderly Convenient once-daily dosing Limitations: Modest HbA1c reduction (0.50.8%) Not effective in Type 1 Diabetes Less potent than GLP-1 analogs or SGLT2 inhibitors Conclusion: DPP-4 inhibitors are a safe, effective, and well-tolerated option for many patients with T2DM especially those needing an add-on to metformin or who can't tolerate injectables